1. Home
  2. SOPH vs MCI Comparison

SOPH vs MCI Comparison

Compare SOPH & MCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$4.82

Market Cap

367.7M

Sector

Health Care

ML Signal

HOLD

Logo Barings Corporate Investors

MCI

Barings Corporate Investors

HOLD

Current Price

$17.70

Market Cap

362.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOPH
MCI
Founded
2011
1971
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
367.7M
362.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SOPH
MCI
Price
$4.82
$17.70
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$7.50
N/A
AVG Volume (30 Days)
89.3K
63.0K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
8.46%
EPS Growth
N/A
N/A
EPS
N/A
1.82
Revenue
N/A
N/A
Revenue This Year
$23.09
N/A
Revenue Next Year
$19.57
N/A
P/E Ratio
N/A
$9.74
Revenue Growth
N/A
N/A
52 Week Low
$2.59
$17.24
52 Week High
$5.70
$23.00

Technical Indicators

Market Signals
Indicator
SOPH
MCI
Relative Strength Index (RSI) 45.78 38.73
Support Level $4.55 $17.28
Resistance Level $4.86 $18.19
Average True Range (ATR) 0.25 0.40
MACD -0.02 0.07
Stochastic Oscillator 30.67 37.89

Price Performance

Historical Comparison
SOPH
MCI

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

About MCI Barings Corporate Investors

Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.

Share on Social Networks: